Abstract
Sleep disturbances are common in chronic obstructive pulmonary disease (COPD) and are often associated with sleep disordered breathing in the form of nocturnal oxygen desaturation, obstructive sleep apnea (OSA), and hypoventilation. The respiratory changes during sleep in COPD have profound effects on sleep quality and quality of life. In addition, the physiologic alterations that result from the disordered breathing likely aggravate certain COPD-related complications, such as pulmonary hypertension, and possibly may increase mortality. Recently, the focus on specific clinical phenotypes such as upper lobe predominant emphysema, frequent exacerbators, and presence of peripheral muscle dysfunction have advanced the approaches to therapy that are affecting outcomes. It is likely that patients with coexistent COPD and sleep disordered breathing (the overlap syndrome) define another clinical phenotype that have a significant impact on the natural history of the disease. Studies have shown a high prevalence of OSA among patients with COPD and that such patients have a higher mortality despite treatment. This effect could perhaps be mediated via mechanisms involving comorbidities, including cardiovascular disease and metabolic syndromes. Current interventions, like supplemental oxygen, positive airway pressure support, and lung volume reduction improve the well being and survival of some patients with COPD, but the optimal therapy for the COPD overlap phenotype remains to be determined.
Keywords: Overlap syndrome, chronic obstructive pulmonary disease, sleep apnea, chronic bronchitis, emphysema, hypoventilation
Current Respiratory Medicine Reviews
Title: Chronic Obstructive Pulmonary Disease and Sleep Disordered Breathing - The Overlap Syndrome: An Evolving Clinical Phenotype
Volume: 6 Issue: 2
Author(s): Christopher Halpin, Samuel Krachman and Wissam Chatila
Affiliation:
Keywords: Overlap syndrome, chronic obstructive pulmonary disease, sleep apnea, chronic bronchitis, emphysema, hypoventilation
Abstract: Sleep disturbances are common in chronic obstructive pulmonary disease (COPD) and are often associated with sleep disordered breathing in the form of nocturnal oxygen desaturation, obstructive sleep apnea (OSA), and hypoventilation. The respiratory changes during sleep in COPD have profound effects on sleep quality and quality of life. In addition, the physiologic alterations that result from the disordered breathing likely aggravate certain COPD-related complications, such as pulmonary hypertension, and possibly may increase mortality. Recently, the focus on specific clinical phenotypes such as upper lobe predominant emphysema, frequent exacerbators, and presence of peripheral muscle dysfunction have advanced the approaches to therapy that are affecting outcomes. It is likely that patients with coexistent COPD and sleep disordered breathing (the overlap syndrome) define another clinical phenotype that have a significant impact on the natural history of the disease. Studies have shown a high prevalence of OSA among patients with COPD and that such patients have a higher mortality despite treatment. This effect could perhaps be mediated via mechanisms involving comorbidities, including cardiovascular disease and metabolic syndromes. Current interventions, like supplemental oxygen, positive airway pressure support, and lung volume reduction improve the well being and survival of some patients with COPD, but the optimal therapy for the COPD overlap phenotype remains to be determined.
Export Options
About this article
Cite this article as:
Halpin Christopher, Krachman Samuel and Chatila Wissam, Chronic Obstructive Pulmonary Disease and Sleep Disordered Breathing - The Overlap Syndrome: An Evolving Clinical Phenotype, Current Respiratory Medicine Reviews 2010; 6(2) . https://dx.doi.org/10.2174/157339810791171232
DOI https://dx.doi.org/10.2174/157339810791171232 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Lipid Mediator Profiling in Pulmonary Disease
Current Pharmaceutical Biotechnology Effect of Leptin on Vascular Nitric Oxide and Endothelial Function
Current Hypertension Reviews The Contribution of Oxazolidinone Frame to The Biological Activity of Pharmaceutical Drugs and Natural Products
Mini-Reviews in Medicinal Chemistry A Review of Hypertension Management in Atrial Fibrillation
Current Hypertension Reviews Sustained Release of Diltiazem Hydrochloride from Chitosan Microcapsules
Current Drug Delivery Identification of Genes for a Complex Trait: Examples from Hypertension
Current Pharmaceutical Biotechnology Modulation of Heart Rate by Acute or Chronic Aerobic Exercise. Potential Effects on Blood Pressure Control
Current Pharmaceutical Design Regulation of the Activity of the Human Drug Metabolizing Enzyme Arylamine N-Acetyltransferase 1: Role of Genetic and Non Genetic Factors
Current Pharmaceutical Design Role of Insulin Signaling in the Interaction Between Alzheimer Disease and Diabetes Mellitus: A Missing Link to Therapeutic Potential
Current Aging Science The Evaluation and Utilization of Marine-derived Bioactive Compounds with Anti-obesity Effect
Current Medicinal Chemistry Developing Stress Assessment forms for Thai Cancer Patients: The Thai Version of the Modified Symptoms of Stress Inventory (Modified SOSI)
Current Psychiatry Research and Reviews The Risks and Benefits of Therapy with Aldosterone Receptor Antagonist Therapy
Current Drug Safety Triptan-Induced Torsades de Pointes and Ventricular Fibrillation Cardiac Arrest: Case Report and Review of the Literature
Current Drug Safety Dihydropyridine Receptor Blockade in the Treatment of Asthma
Recent Patents on Inflammation & Allergy Drug Discovery Cyclooxygenase-2 Inhibitors: A Painful Lesson
Cardiovascular & Hematological Disorders-Drug Targets Cardiac Remodeling and Exercise Training in Hypertension
Current Hypertension Reviews Psychopathological Behaviour and Cognition in Morbid Obesity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Precision Medicine in the Renin-Angiotensin System: Therapeutic Targets and Biological Variability
Current Drug Targets Synthesis and Biological Activity of Prostaglandin Analogs Containing Heteroatoms in the Cyclopentane Ring
Current Organic Chemistry Thiazolidinediones and Type 2 Diabetes: From Cellular Targets to Cardiovascular Benefit
Current Drug Targets